000			01469 a2200373 4500
005			20250515071405.0
264		0	_c20070628
008			200706s 0 0 ger d
022			_a1439-4413
024	7		_a10.1055/s-2007-982025 _2doi
040			_aNLM _beng _cNLM
100	1		_aJoussen, A M
245	0	0	_a[Molecular pathogenesis of ocular vascular disease--anti-angiogenesis as a therapeutic concept]. _h[electronic resource]
260			_bDeutsche medizinische Wochenschrift (1946) _cJun 2007
300			_a1268-72 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAngiogenesis Inhibitors _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAptamers, Nucleotide _xtherapeutic use
650	0	4	_aBevacizumab
650	0	4	_aDiabetic Angiopathies _xdrug therapy
650	0	4	_aDiabetic Retinopathy _xdrug therapy
650	0	4	_aHumans
650	0	4	_aInfant, Newborn
650	0	4	_aMacular Degeneration _xdrug therapy
650	0	4	_aNeovascularization, Pathologic _xdrug therapy
650	0	4	_aRanibizumab
650	0	4	_aRetinal Diseases _xdrug therapy
650	0	4	_aRetinopathy of Prematurity _xdrug therapy
650	0	4	_aVascular Diseases _xdrug therapy
773	0		_tDeutsche medizinische Wochenschrift (1946) _gvol. 132 _gno. 23 _gp. 1268-72
856	4	0	_uhttps://doi.org/10.1055/s-2007-982025 _zAvailable from publisher's website
999			_c17081556 _d17081556